Stonepine Capital Management, LLC
Q2 2026 13F filing
Updated 26 days ago87 disclosed positions worth $177.3M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | V VSTM VERASTEM INC | $12.8M | 3.35M | 7.22% | — |
| 2 | E EOLS EVOLUS INC | $11M | 1.59M | 6.23% | — |
| 3 | T TENX TENAX THERAPEUTICS INC | $9.6M | 660.0K | 5.42% | — |
| 4 | N NKTR NEKTAR THERAPEUTICS | $8.4M | 120.7K | 4.75% | — |
| 5 | A ADMA ADMA BIOLOGICS INC | $8M | 650.0K | 4.48% | — |
| 6 | A ADMA ADMA BIOLOGICS INC | $6.2M | 740.0K | 3.49% | — |
| 7 | C CAMP CAMP4 THERAPEUTICS CORP | $6.1M | 1.39M | 3.43% | — |
| 8 | I INSM INSMED INC | $5.6M | 40.0K | 3.16% | — |
| 9 | ? N/A ELOXX PHARMACEUTICALS INC | $5.5M | 397.2K | 3.11% | — |
| 10 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $5.5M | 200.0K | 3.10% | — |
| 11 | K KZIA KAZIA THERAPEUTICS LTD | $4.9M | 345.2K | 2.74% | — |
| 12 | M MDT MEDTRONIC PLC | $4.4M | 50.0K | 2.47% | — |
| 13 | I INDV INDIVIOR PHARMACEUTICALS INC | $4.1M | 100.0K | 2.31% | — |
| 14 | C CRBP CORBUS PHARMACEUTICALS HLDGS | $4M | 425.0K | 2.25% | — |
| 15 | A ABT ABBOTT LABORATORIES | $3.8M | 40.0K | 2.14% | — |
| 16 | M MSLE SATELLOS BIOSCIENCE INC | $3.7M | 491.6K | 2.10% | — |
| 17 | J JPM-PM ZEVRA THERAPEUTICS INC | $3.7M | 258.7K | 2.09% | — |
| 18 | A ABEO ABEONA THERAPEUTICS INC | $3.4M | 557.3K | 1.94% | — |
| 19 | B BSX BOSTON SCIENTIFIC CORP | $3.3M | 50.0K | 1.83% | — |
| 20 | ? N/A EDESA BIOTECH INC | $3.2M | 456.4K | 1.80% | — |
| 21 | E EOLS EVOLUS INC | $3.1M | 420.0K | 1.78% | — |
| 22 | B BMRN BIOMARIN PHARMACEUTICAL INC | $3.1M | 50.0K | 1.76% | — |
| 23 | C CABA CABALETTA BIO INC | $2.9M | 917.1K | 1.61% | — |
| 24 | ? N/A AN2 THERAPEUTICS INC | $2.7M | 551.7K | 1.51% | — |
| 25 | ? N/A XILIO THERAPEUTICS INC | $2.2M | 226.0K | 1.22% | — |
| 26 | A ACET ADICET BIO INC | $2.1M | 245.5K | 1.20% | — |
| 27 | X XERS XERIS BIOPHARMA HOLDINGS INC | $2.1M | 280.0K | 1.18% | — |
| 28 | ? N/A TELA BIO INC | $2M | 2.66M | 1.13% | — |
| 29 | A AYTU AYTU BIOPHARMA INC | $2M | 912.9K | 1.11% | — |
| 30 | C CRIS CURIS INC | $1.7M | 3.31M | 0.98% | — |
| 31 | S SPRB SPRUCE BIOSCIENCES INC | $1.6M | 28.8K | 0.88% | — |
| 32 | H HRTX HERON THERAPEUTICS INC | $1.5M | 1.00M | 0.85% | — |
| 33 | S SIBN SI BONE INC | $1.5M | 100.0K | 0.85% | — |
| 34 | O OKYO OKYO PHARMA LTD | $1.3M | 863.0K | 0.73% | — |
| 35 | N NMRA NEUMORA THERAPEUTICS INC. | $1.3M | 500.0K | 0.71% | — |
| 36 | K KTTAW PASITHEA THERAPEUTICS CORP | $1.1M | 2.20M | 0.64% | — |
| 37 | S SLGL SOL-GEL TECHNOLOGIES LTD | $1.1M | 14.5K | 0.61% | — |
| 38 | L LUNG PULMONX CORP | $1.1M | 815.4K | 0.60% | — |
| 39 | ? N/A X4 PHARMACEUTICALS INC | $1.1M | 225.0K | 0.59% | — |
| 40 | A ARDX ARDELYX INC | $1.1M | 150.0K | 0.59% | — |
| 41 | D DCTH DELCATH SYS INC | $1M | 100.0K | 0.56% | — |
| 42 | ? N/A IN8BIO INC | $980K | 695.3K | 0.55% | — |
| 43 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $974K | 50.0K | 0.55% | — |
| 44 | ? N/A QUOIN PHARMACEUTICALS LTD | $966K | 199.5K | 0.54% | — |
| 45 | M MXCT MAXCYTE INC | $924K | 751.6K | 0.52% | — |
| 46 | P PHAT PHATHOM PHARMACEUTICALS INC | $922K | 85.0K | 0.52% | — |
| 47 | ? N/A AZITRA INC | $887K | 5.29M | 0.50% | — |
| 48 | C CNTB CONNECT BIOPHARMA HLDGS LTD | $867K | 364.3K | 0.49% | — |
| 49 | H HELP CYBIN INC | $855K | 129.3K | 0.48% | — |
| 50 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $835K | 25.0K | 0.47% | — |